Table 2 |
|||
|
p42/p44 MAP kinase inactivating agents in Prostatic cells |
|||
| Endogenous |
|||
| Calcitonin |
DU145 |
? |
100 |
| 15-(S)-HETE |
PC3 |
? |
38 |
| Exogenous |
|||
| Lovastatin (HMG-CoA reductase inhibitor) |
PC3 |
? |
33 |
| Grape seed extracta |
DU145 |
? |
101,102 |
| Methyl selenium molecules |
DU145 |
? |
27,103,104 |
| Silibinin |
LNCaP, DU145 |
? |
105 |
| Silymarin |
DU145 |
? |
51 |
| Genistein |
DU145, AT6.3 |
? |
51,106 |
| Kaempferol |
AT6.3 |
? |
106 |
| Biochanin A |
AT6.3 |
? |
106 |
| Quercetin |
PC3 |
? |
91 |
| Phenylacetate |
LNCaP |
? |
34 |
|
a Can activate ERK at higher doses | |||
Maroni et al. Cell Communication and Signaling 2004 2:5 doi:10.1186/1478-811X-2-5 |
|||
